AuraSense™
Informing Neurology Through Play
Our Inspiring Brand
hapticsEM™ by AuraSense Prototype
Our Team
David Charlot, PhD, MSEng
CEO & Founder
Amber Ivey, JD, MPA
AI + Data Advisor & Co-Founder
Gulmohar Ahluwalia, MBA
Chief Business Officer
Advisors
Maryam Saleh, PhD
Innovation & Entrepreneurship
Sara Myers, PhD
Biomechanics
Claudio Pacchierotti, PhD
Haptics & Robotics
Our Partners
Our Journey
Started in the Summer of 2022
Showcasing for DoD
Used opportunity to refine product messaging for AuraSense products at NSIN DES in August 2022.
A Competitive Start
Executive Chairman, Head of Product, and co-Founder Dr. David Charlot participated in the CRANE IP Pitch Competition placing 2nd. Wins $4K to get the company started.
Demo Day Graduation
One of 6 teams showcasing at NSIN Foundry 2022 Demo Day in September 2022. Took home the $20K prize to accelerate company product development.
Showcasing at Cade
Showcased our early prototype as joyful finalists for the 2022 CADE Fibonacci Prize.
TechCrunch Disrupt 2022
Showcased our early prototype Oct 18-21 in SF.
A 4 Minute Quick Pitch at Black Men Talk Tech
Dr. Charlot, wins 2nd Place at BMTT in Miami in October 2022.
AR + Haptics
Team AuraSense showcases early prototype with partners Lenovo and Phibonacci at CES 2023.
Interviewing Dr. Sara Myers about XR and Healthcare
Dr. Charlot interviews industry expert Dr. Sara Myers at VRARA Healthcare Summit October 31, 2022.
Vegas with Love
Showcased early AuraSense prototype at CES 2023 in Las Vegas.
Joining AARP
Excited to join AARPs AgeTech Collaborative to explore AuraSense's product value. Met the Age Collaborative Team in Vegas.
A Trip to Lake Nona, FL
Team AuraSense showcased at the annual Lake Nona Impact Forum hosted by KPMG in March 2023
A New Home
AuraSense joins mHUB in Chicago to accelerate development of our first product in March 2023
TechCrunch 2023
Showcasing our hardware development progress from mHUB at TechCrunch Disrupt 2023. Honored to be in the Battlefield 200
Growth
AuraSense joins HAX in Newark, NJ in September 2023 to sprint through hardware development for upcoming Q2 2024 validation studies
